News

Hong Kong – – October 02, 2026 -- Ascletis Pharma Inc. (HKEX: 1672) presented preclinical data showing its ASC36_35FDC injectable combination drove a 24.8% body-weight reduction in a diet-induced obesity rat model on Day 14, outperforming two competitor co-formulations tested under identical dosing conditions.

The data were unveiled in a short oral discussion at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting, held September 28–October 2, 2026, in Milan, Italy.

Costa Mesa, Calif. – October 02, 2026 -- Nearly 40% of women with postpartum depression showed a hyperfrontal/anterior cingulate cortex brain-activity pattern, more than double the 19.4% rate found in patients with major depression, according to new research from Dr. Daniel Amen and colleagues at Amen Clinics.

Brain scan comparison covers 26,135 patients across two depression groups

Researchers analyzed brain SPECT imaging scans from 58 women diagnosed with postpartum depression (PPD) and compared them against scans from 26,077 people with major depression. Each scan was classified into one of six brain-function categories: hyperfrontal/ACC, limbic, hypofrontal, toxic/diffuse low perfusion, brain trauma/acquired injury, or mixed patterns.

Jeddah – October 02, 2026 -- The Mysk Al Wadi Jeddah Hotel, the first Mysk-branded luxury property in Saudi Arabia, will open in September 2026 after builders treated over 2,000 cubic meters of concrete with crystalline waterproofing admixture to counter high groundwater and chloride exposure at the Red Sea construction site.

General contractor specified PENETRON ADMIX for below-grade structures exposed to groundwater

Faraj Abdulkarim Est, the project's general contractor, required a waterproofing solution for below-grade concrete after excavation depths revealed elevated groundwater levels at the site in Jeddah's Obhur district, near the Jeddah Corniche. Sam Annous, Managing Director of Penetron Saudi Arabia, said the hotel's proximity to the Red Sea made resilience against chloride-rich conditions a parallel priority alongside groundwater control.

Stockholm – October 02, 2026 -- Skanska has signed an additional USD 60 million (SEK 560 million) contract with Lee Health for the construction of a new hospital and medical office building in Fort Myers, Florida. The sum will be booked in Skanska's US order intake for the third quarter of 2026.

Contract amendment covers interior and mechanical work for bed tower expansion

The amendment adds interior build-out finishes and mechanical, electrical and plumbing work tied to the project's West Bed Tower expansion. It builds on the original full project agreement between Skanska and Lee Health.

Full project scope totals roughly 50,200 square meters of hospital and medical office space

The complete contract scope includes a five-story hospital of approximately 38,600 square meters (416,000 square feet), a central energy plant, and an 11,600-square-meter (125,000-square-foot) medical office building that houses an ambulatory surgery center.

Los Angeles – October 02, 2026 -- FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) showcased the EAI Robotics business of Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) at IROS 2026 in Pittsburgh, Pennsylvania, held September 28-30, 2026, as the two companies advance a non-binding term sheet that values the robotics unit at approximately $200 million.

All-New Futurist robot draws most attendee interest at Pittsburgh conference

FF displayed multiple EAI robot products built on its "One-Brain Multi-Form Multi-Capability" EAI Robot World 2.0 architecture. The All-New Futurist unit attracted particular attention for its mobile operation and flexible task execution across demonstrated scenarios. The company also introduced its "Built in USA" Acceleration Program during the three-day event, one of the largest robotics research conferences globally.

Stockholm – October 02, 2026 -- Autoliv, Inc. (NYSE: ALV; SSE: ALIVsdb) has appointed Natalie Draisin and Thomas Manfred Müller to its Research Advisory Board, expanding a panel of external experts that guides the automotive safety supplier's long-term research agenda.

Autoliv broadens external expertise with public health and automotive industry veterans

Natalie Draisin serves as Director of the North American Office and United Nations Representative at FIA Foundation and is an External Affiliate at Johns Hopkins Bloomberg School of Public Health. Thomas Manfred Müller, PhD, is a board member, advisor and business angel with executive experience at Audi, BMW, Volvo Cars, and Volkswagen Group.

Valby – October 02, 2026 -- H. Lundbeck A/S will present late-breaking Phase III data on its multiple system atrophy (MSA) drug candidate amlenetug alongside new Parkinson's disease pipeline results at the International Congress of Parkinson's Disease and Movement Disorders (MDS) 2026 in Seoul, South Korea, running October 4-8.

MASCOT trial enrolled 401 participants across a global Phase III program

The late-breaking oral presentation will detail baseline characteristics of participants in MASCOT (NCT06706622), Lundbeck's ongoing Phase III trial of amlenetug in MSA. The trial enrolled 401 participants with clinically probable or established MSA, covering both MSA-C and MSA-P subtypes, across sites in North America, Europe, Asia and Australia. The double-blind treatment period runs 72 weeks, comparing high- and low-dose amlenetug against placebo, with results expected in Q3 2027.

Seoul – October 02, 2026 -- AUTOCRYPT has established a Public Key Infrastructure (PKI) system for Plug&Charge (PnC) services in South Korea, validated across electric vehicles from six global automotive brands.

Six automakers validate shared authentication framework

The PKI infrastructure was tested on vehicles from Hyundai Motor, Kia, KG Mobility, BMW, Mercedes-Benz and Tesla, enabling these brands to connect to charging point operators (CPOs) through a single authentication system rather than separate proprietary frameworks.

Stockholm – October 02, 2026 -- Skanska has signed a USD 271 million (approximately SEK 2.5 billion) contract with NAVFAC Mid-Atlantic to construct a new homeport pier at Naval Station Newport in Newport, Rhode Island. The deal will be booked in Skanska's U.S. order intake for the third quarter of 2026.

New Pier Replaces Aging Infrastructure at Active Navy Installation

The project calls for the demolition of the existing Pier 1, which measures approximately 30 meters by 482 meters (100 feet by 1,580 feet). In its place, Skanska will build a smaller, modern pier spanning roughly 24 meters by 305 meters (80 feet by 1,000 feet), engineered to berth four U.S. Coast Guard Offshore Patrol Cutters.

London – October 02, 2026 -- Samfara has completed the acquisition of Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance active pharmaceutical ingredients, marking the London-based life sciences investment firm's first deal. The transaction sees Samfara buy the business from Chr. Olesen and funds managed by Signet Healthcare Partners, with Chief Executive Thomas Moestrup co-investing alongside the new owner. Financial terms were not disclosed.

Chr. Olesen Synthesis supplies opioid-disorder and ADHD treatment ingredients globally

Based near Copenhagen, Chr. Olesen Synthesis develops and manufactures APIs and advanced intermediates specialising in controlled substances, including buprenorphine for opioid use disorder and lisdexamfetamine for ADHD. Its cGMP-certified plant in Hvidovre has been in commercial production since 2015, supplying pharmaceutical companies across Europe, North America and the Middle East.